Authors: Tsavaris, N Skarlos, D Bacoyiannis, C Aravantinos, G Kosmas, C Retalis, G Panopoulos, C Vadiaka, M Dimitrakopoulos, A Kostantinidis, K Mitropoulos, D Bougas, D Pantazopoulos, D Kosmidis, P

Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690

Authors: Ioakim-Liossi, A Pantazopoulos, D Karakitsos, P Athanassiadou, P Aroni, K Chourdakis, N Giachnaki, A Athanassiades, P

Citation: A. Ioakim-liossi et al., DNA ploidy and p53 protein expression in superficial transitional cell carcinoma of the bladder, CYTOPATHOLO, 11(2), 2000, pp. 96-103

Authors: Ioakim-Liossi, A Pantazopoulos, D Karakitsos, P Athanassiadou, P Aroni, K Giahnaki, AE Athanassiades, P

Citation: A. Ioakim-liossi et al., p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder, ANAL QUAN C, 22(3), 2000, pp. 223-228

Authors: Stravodimos, K Constantinides, C Manousakas, T Pavlaki, C Pantazopoulos, D Giannopoulos, A Dimopoulos, C

Citation: K. Stravodimos et al., Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: Divergent correlation with clinicopathological parameters, ANTICANC R, 20(5C), 2000, pp. 3823-3828

Authors: Dimopoulos, MA Bakoyannis, C Georgoulias, V Papadimitriou, C Moulopoulos, LA Deliveliotis, C Karayannis, A Varkarakis, I Aravantinos, G Zervas, A Pantazopoulos, D Fountzilas, G Bamias, A Kyriakakis, Z Anagnostopoulos, A Giannopoulos, A Kosmidis, P

Citation: Ma. Dimopoulos et al., Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(11), 1999, pp. 1385-1388

Authors: Ioakim-Liossi, AG Karakitsos, PJ Pantazopoulos, D Aroni, KG Athanossiadou, P

Citation: Ag. Ioakim-liossi et al., Image cytometric DNA analysis and Proliferating Cell Nuclear Antigen (PCNA) expression in transitional cell carcinoma of the bladder, CANCER DET, 23(5), 1999, pp. 401-407